Files in This Item:
   
Thumbnail12_5_2006_548_554.pdf

View/Open

Title: Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran
Authors: Alizadeh, A.
Ranjbar, M.
Kashani, K.M.
Taheri, M.M.
Bodaghi, M.
Issue Date: 2006
Language: English
Abstract: We examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole [400 mg, once daily for 5 days] or metronidazole [250 mg, 3 times a day for 5 days]. Demographic data of the patients, results of stool for Giardia trophozoites before and after treatment, and drug side- effects were recorded. After treatment 6 [10.0%] of the albendazole group had trophozoites compared with 14 [23.3%] of metronidazole group [P < 0.05]. Patients in the albendazole group had fewer side- effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis
Description: 548-554
Keywords: Feces
Feces
Albendazole
Albendazole
Metronidazole
Subject: Giardiasis
URI: http://www.who.int/iris/handle/10665/117116
ISSN: 1020-3397
Other Identifiers: http://applications.emro.who.int/emhj/1205/12_5_2006_548_554.pdf
Appears in Collections:EMRO Journal Articles (EMHJ)



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.